Showing 4,161 - 4,180 results of 28,667 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((ng decrease) OR (nn decrease)) ))', query time: 0.70s Refine Results
  1. 4161
  2. 4162

    X-axis shows the MEHP quartiles, and Y-axis shows each hormone level. by Atsuko Araki (641415)

    Published 2014
    “…<p>The adjusted LSMs (95% confident intervals) of each hormone level in cord blood in relation to the MEHP concentration quartile fit to all study participants are shown with <i>p</i>-value for trend, and <i>p</i> for interaction, respectively, for (<b>A</b>) T/E2 (0.017, 0.846), (<b>B</b>) P4 (0.010, 0.520), and (<b>C</b>) inhibin B (0.004, 0.042). First quartile (≦5.90 ng/mL) is also compared to the 2nd (5.91–10.39 ng/mL), 3rd (10.40–15.30 ng/mL) and 4th (15.31+ ng/mL) quartile MEHP. …”
  3. 4163

    MiR-34a expression is reduced in primary canine OSA tumors and OSA cell lines. by Cecilia M. Lopez (4729986)

    Published 2018
    “…While 2/8 samples showed increased miR-34a expression in metastatic tissues compared to primary tumor biopsies, 4/8 (50%) had decreased miR-34a expression; miR-34a levels were unchanged in 2 patients. …”
  4. 4164

    Participant characteristics. by Ronald Kusolo (13200268)

    Published 2025
    “…Uganda conducted its first nationally representative NCD risk factor survey in 2014, and a second in 2023. We analyzed the prevalence of the common NCD risk factors to assess changes in these between 2014 and 2023. …”
  5. 4165
  6. 4166
  7. 4167
  8. 4168
  9. 4169

    Uganda 2023 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

    Published 2025
    “…Uganda conducted its first nationally representative NCD risk factor survey in 2014, and a second in 2023. We analyzed the prevalence of the common NCD risk factors to assess changes in these between 2014 and 2023. …”
  10. 4170

    Uganda 2014 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

    Published 2025
    “…Uganda conducted its first nationally representative NCD risk factor survey in 2014, and a second in 2023. We analyzed the prevalence of the common NCD risk factors to assess changes in these between 2014 and 2023. …”
  11. 4171
  12. 4172

    Binding of <i>PC3/Tis21</i> to the <i>Id3</i> promoter and corresponding decrease of <i>Id3</i> mRNA. by Stefano Farioli-Vecchioli (256006)

    Published 2009
    “…The <i>Id3</i> promoter construct comprised 1592 nt 5′ to the putative transcription start, placed upstream of a luciferase reporter (construct pGL3-<i>Id3</i>-prom/-1592). …”
  13. 4173
  14. 4174
  15. 4175
  16. 4176

    Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

    Published 2016
    “…<div><p>Background</p><p>Dyslipidemia as a risk factor of cardiovascular disease is common especially in HIV-infected patients who are using protease inhibitors (PIs) including atazanavir. …”
  17. 4177

    Optic nerve head degeneration and decrease in RGCs observed in <i>Vav2<sup>−/−</sup>Vav3<sup>−/−</sup></i> mice with elevated IOP. by Keiko Fujikawa (253775)

    Published 2010
    “…In those retinas, RGCs are decreased. Scale bars, from left to right side: 500 µm, 100 µm, and 50 µm. …”
  18. 4178
  19. 4179
  20. 4180

    Expression and distribution of p-JNK and JNK proteins in the P7 rat brain after HI as detected by Western blot analysis and fluorescence immunolabeling. by Deyuan Li (769599)

    Published 2015
    “…Total JNK protein was not obviously changed at different time points compared with sham controls (A). However, p-JNK protein levels transiently decreased at 0.5 h, increased at 6 and 24 h, peaked at 48 h, and lasted until 72 h (A). …”